A

Alpha-9 Theranostics Inc.

15 employees

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Basic info

biotechnology research

Biotechnology

Clinical Trials

Cancer

Radiopharmaceuticals

Product Research

Radiotherapy

PET Imaging

Medical

Nuclear Medicine

2018

$75M

from 5 investors over 5 rounds

A

Alpha-9 Theranostics Inc. raised $75M on December 14, 2022

Investors: Nextech Invest, Samsara BioCapital, Longitude Capital and Quark Venture

A

Alpha-9 Theranostics Inc. raised $8.9M on April 28, 2021

Investors: Longitude Capital